GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (SHSE:688366) » Definitions » 3-Year FCF Growth Rate

Shanghai Haohai Biological Technology Co (SHSE:688366) 3-Year FCF Growth Rate : 74.50% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Haohai Biological Technology Co 3-Year FCF Growth Rate?

Shanghai Haohai Biological Technology Co's Free Cash Flow per Share for the three months ended in Mar. 2024 was ¥-0.46.

During the past 12 months, Shanghai Haohai Biological Technology Co's average Free Cash Flow per Share Growth Rate was -707.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 74.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 10 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Shanghai Haohai Biological Technology Co was 74.50% per year. The lowest was -34.00% per year. And the median was -7.75% per year.


Competitive Comparison of Shanghai Haohai Biological Technology Co's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's 3-Year FCF Growth Rate falls into.



Shanghai Haohai Biological Technology Co 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Shanghai Haohai Biological Technology Co  (SHSE:688366) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Shanghai Haohai Biological Technology Co 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co (SHSE:688366) Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. It is also engaged in the research and development of biological engineering, pharmaceutical and ophthalmology products, and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.

Shanghai Haohai Biological Technology Co (SHSE:688366) Headlines

No Headlines